Genomic regions associated with multiple sclerosis are active in B cells.
More than 50 genomic regions have now been shown to influence the risk of multiple sclerosis (MS). However, the mechanisms of action, and the cell types in which these associated variants act at the molecular level remain largely unknown. This is especially true for associated regions containing no...
Enregistré dans:
Auteurs principaux: | Giulio Disanto, Geir Kjetil Sandve, Antonio J Berlanga-Taylor, Julia M Morahan, Ruth Dobson, Gavin Giovannoni, Sreeram V Ramagopalan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/541fa2c204794509a8299aba3a99f8e9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Neuroprotection in a novel mouse model of multiple sclerosis.
par: Katie Lidster, et autres
Publié: (2013) -
Measuring treatment response to advance precision medicine for multiple sclerosis
par: Peter A. Calabresi, et autres
Publié: (2021) -
OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
par: E. P. Evdoshenko, et autres
Publié: (2014) -
Differential expression profile of gluten-specific T cells identified by single-cell RNA-seq.
par: Ying Yao, et autres
Publié: (2021) -
Pregnancy-induced effects on memory B-cell development in multiple sclerosis
par: Malou Janssen, et autres
Publié: (2021)